Table 3 Incidence Rates and Hazard Ratios for Stage 4 Cardiovascular-Kidney-Metabolic (CKM) syndrome among Jackson Heart Study participants with Stage 1, 2 and 3 CKM syndrome and Associated Risk Factors.
 | Number of participants | Number of participants developing Stage 4 CKM | Person-years of follow up | Incidence rate per 1000/person years (95% CI) | Hazard ratio (95% CI) compared to participants with stage 1 CKM | ||
---|---|---|---|---|---|---|---|
CKM stage 1 | Â | Â | Â | Â | Model 1 | Model 2 | Model 3 |
Overall | 429 | 8 | 4915 | 1.6 (0.4, 2.7) | Reference | Reference | Reference |
CKM stage 2 | Â | ||||||
Overall | 1464 | 133 | 15737 | 8.4 (7.0, 9.8) | 3.31 (1.60, 6.85) | 3.23 (1.56, 6.68) | 3.04 (1.47, 6.29) |
Hypertension | 1166 | 113 | 12445 | 9.0 (7.4, 10.7) | 1.29 (0.80, 2.08) | 1.35 (0.84, 2.19) | 1.31 (0.87, 2.12) |
Diabetes | 232 | 43 | 2362 | 18.2 (12.7, 23.6) | 2.47 (1.71, 3.57) | 2.68 (1.85, 3.89) | 2.56 (1.75, 3.75) |
Hypertriglyceridemia | 461 | 57 | 4834 | 11.7 (8.7, 14.8) | 1.69 (1.19, 2.38) | 1.63 (1.15, 2.30) | 1.63 (1.15, 2.31) |
Metabolic Syndrome | 623 | 80 | 6511 | 12.2 (9.5, 14.9) | 2.19 (1.54, 3.11) | 2.24 (1.57, 3.18) | 2.14 (1.49, 3.08) |
Moderate – High risk CKD | 575 | 56 | 6177 | 9.0 (6.6, 11.4) | 0.92 (0.65, 1.31) | 0.88 (0.62, 1.25) | 0.88 (0.62, 1.25) |
CKM stage 3 | Â | Â | Â | ||||
Overall | 225 | 62 | 1897 | 32.6 (24.5, 40.8) | 6.28 (2.63, 15.03) | 5.89 (2.46, 14.10) | 4.86 (1.97, 12.00) |
Hypertension | 214 | 61 | 1784 | 34.1 (25.8, 42.7) | 2.59 (0.35, 18.91) | 2.80 (0.38, 20.60) | 2.92 (0.39, 21.44) |
Uncontrolled treated hypertension | 127 | 39 | 1011 | 38.5 (26.4, 50.6) | 1.25 (0.74, 2.11) | 1.22 (0.71, 2.08) | 1.25 (0.73, 2.13) |
Uncontrolled untreated hypertension | 33 | 5 | 308 | 16.2 (2.0, 30.4) | 0.53 (0.21, 1.33) | 0.54 (0.21, 1.40) | 0.54 (0.21, 1.38) |
Untreated hypertension | 101 | 26 | 838 | 31.0 (19.0, 42.9) | 0.84 (0.50, 1.39) | 0.83 (0.50, 1.38) | 0.84 (0.50, 1.39) |
Controlled treated hypertension | 129 | 47 | 996 | 47.1 (33.6, 60.6) | 2.28 (1.24, 4.22) | 2.30 (1.24, 4.24) | 2.27 (1.23, 4.20) |
Diabetes | 99 | 37 | 752 | 49.1 (33.3, 64.9) | 2.00 (1.20, 3.34) | 1.96 (1.17, 3.28) | 1.98 (1.18, 3.32) |
Hypertriglyceridemia | 72 | 18 | 574 | 31.3 (16.8, 45.7) | 1.15 (0.66, 2.01) | 1.16 (0.66, 2.02) | 1.20 (0.68, 2.10) |
Metabolic Syndrome | 131 | 40 | 1073 | 37.2 (25.7, 48.8) | 1.52 (0.89, 2.59) | 1.52 (0.89, 2.58) | 1.45 (0.84, 2.48) |
Moderate – High risk CKD | 131 | 38 | 1069 | 35.5 (24.2, 46.8) | 1.02 (0.61, 1.72) | 1.04 (0.62, 1.75) | 1.02 (0.61, 1.72) |